Logan Steele
Scleroderma is an autoimmune condition that causes skin and connective tissue to harden and thicken, affecting the muscles, blood vessels, joints, and internal organs. While the condition typically affects the skin, it can also cause muscle weakness and damage. The accumulation of fibrous tissue in the muscles can lead to severe outcomes, including heart disease. Muscle pain and weakness are common symptoms of scleroderma, and the condition can also impact the digestive system, causing swallowing difficulties and heartburn. The heterogeneity of scleroderma-associated muscle involvement poses challenges in diagnosis and therapeutic response assessment.
| Characteristics | Values |
|---|---|
| Muscle weakness | Accumulation of fibrous tissue in muscles |
| Muscle enzymes | Lower levels indicate less ongoing damage to the muscle |
| Mortality | Fibrosing myopathy patients have a higher risk of death from cardiac disease |
| Muscle inflammation | Active inflammation is distinguishable from muscle weakness caused by muscle damage |
| Muscle pain | Aspirin or aspirin-like medications can help |
| Muscle involvement | SSc-associated muscle involvement lacks a gold standard for diagnosis and therapy response |
| Muscle damage | Scleroderma can cause damage to the muscles of the small bowel (small intestine) |
| Muscle movement | Scleroderma can cause abnormally slow movement of food in the digestive process |
Explore related products
What You'll Learn
- Fibrosing myopathy, a subtype of muscle disease, is associated with scleroderma
- Scleroderma can cause muscle inflammation and damage
- The accumulation of fibrous tissue in muscles can lead to severe outcomes, including death
- Muscle pain and weakness are common symptoms of scleroderma
- Systemic sclerosis can cause digestive issues, such as swallowing difficulties and bloating
Fibrosing myopathy, a subtype of muscle disease, is associated with scleroderma
Scleroderma is an autoimmune condition that causes skin and connective tissue to harden and thicken, affecting different parts of the body. It is also known as systemic sclerosis, which should not be confused with localised scleroderma, which only affects the skin. The word scleroderma means hard skin.
People with scleroderma often experience muscle weakness, which can cause difficulty swallowing. This is due to the accumulation of fibrous tissue in their muscles. A subtype of this muscle disease is fibrosing myopathy, which is associated with scleroderma. This subtype is characterised by the absence of inflammation and necrosis in muscle biopsies.
Fibrosing myopathy is associated with a higher risk of mortality, particularly due to cardiac disease. A study found that people with scleroderma and fibrosing myopathy had a mortality rate of 62.5%, compared to 14.3% for those with inflammatory myopathy. This highlights the need for further research and monitoring of this subgroup of scleroderma patients.
The study also found that people with scleroderma and fibrosing myopathy were more likely to have widespread thickening of the skin, impaired lung function, and lower levels of muscle enzymes, indicating less ongoing muscle damage. However, more research is needed to fully understand the causes of muscle weakness in scleroderma and its long-term outcomes.
Hashimoto's and Muscle Twitching: Is There a Link?
You may want to see also
Explore related products
Scleroderma can cause muscle inflammation and damage
Scleroderma is an autoimmune condition called systemic sclerosis, where the immune system attacks the body's own cells, affecting the skin and connective tissue inside the body. The word "scleroderma" means hard skin, and the condition causes skin and connective tissue to harden and thicken, becoming like scar tissue.
When connective tissue hardens, it can affect the functioning of muscles, blood vessels, joints, and internal organs. Systemic sclerosis can cause muscle inflammation and damage, leading to muscle weakness and pain. This is due to the accumulation of fibrous tissue and collagen in the muscles, which can result in the thickening and fibrosis (scarring) of the tissues. The overproduction of collagen can also cause fibrosis or scarring in the lungs, making it harder to transport oxygen into the bloodstream.
Muscle inflammation and damage can manifest in the digestive system, causing dysmotility (abnormally slow movement of food) and difficulty swallowing. This is due to the weakening of the muscles in the oesophagus and small bowel, which can lead to acid reflux, heartburn, and an overgrowth of bacteria in the small intestine. The accumulation of fibrous tissue in the muscles can also lead to severe disease outcomes, including death from heart disease.
While muscle inflammation and damage are common in scleroderma, the causes and long-term outcomes are not yet fully understood. Studies have found that people with scleroderma who experience muscle weakness may have lower levels of muscle enzymes, indicating less ongoing damage to the muscles. However, further research is needed to distinguish active, reversible muscle inflammation from irreversible muscle damage and to develop effective therapeutic responses.
Trulicity and Muscle Loss: What's the Connection?
You may want to see also
Explore related products
The accumulation of fibrous tissue in muscles can lead to severe outcomes, including death
Scleroderma is an autoimmune condition called systemic sclerosis, which affects the skin and connective tissue inside the body. Scleroderma causes the hardening and thickening of the skin and connective tissue, which can impair muscle function. The hardening of connective tissue can stop muscles, blood vessels, and internal organs from functioning properly.
Systemic sclerosis can cause the muscles in the oesophagus to weaken, making swallowing difficult. This is because scleroderma can cause the lower oesophageal sphincter to not close properly, resulting in a backwash of acid and a burning sensation (heartburn). This acid can also injure the lining of the oesophagus, causing scarring and narrowing of the tube.
In addition, scleroderma can cause damage to the muscles of the small bowel (small intestine). The weakened muscles do not work effectively to push food through the bowel, leading to an overgrowth of bacteria and diarrhoea.
A study by Johns Hopkins Rheumatology found that scleroderma patients with fibrosing myopathy were more likely to have widespread thickening of the skin and impaired lung function. They also had a significantly higher mortality rate, with 60% of deaths caused by cardiac disease. Another study found that almost 25% of patients seen at the Johns Hopkins Scleroderma Center between 1990 and 2014 experienced muscle weakness.
While muscle weakness is a known symptom of scleroderma, the causes and long-term outcomes are not yet fully understood. However, the accumulation of fibrous tissue in muscles due to scleroderma can lead to severe outcomes, including death. This is because the condition can cause irreversible muscle damage, affecting the function of vital organs such as the heart and lungs. Therefore, it is important for patients with scleroderma to have regular check-ups with their doctors to monitor their condition and treat any potentially serious complications early on.
Muscle Damage: A Cause of High Creatinine Levels?
You may want to see also
Muscle pain and weakness are common symptoms of scleroderma
The overproduction of collagen, typical of scleroderma, can cause thickening and fibrosis (scarring) of the tissues. This can lead to weakened muscles and abnormally slow movement of food through the digestive system. This is known as dysmotility and can cause swallowing difficulties, heartburn, and pain and swelling around the joints.
In systemic scleroderma, there can also be damage to the muscles of the small bowel (small intestine). The weakened muscles do not effectively push food through the bowel, leading to bacterial overgrowth and diarrhea. The hardening of connective tissue can also affect the lungs, making it more difficult for oxygen to enter the bloodstream.
Fibrosing myopathy is a unique subtype of muscle disease that can be observed in people with scleroderma. It is associated with a higher risk of mortality, especially due to cardiac disease. People with scleroderma who have fibrosing myopathy are more likely to have widespread thickening of the skin and impaired lung function compared to those with inflammatory myopathy.
While muscle pain and weakness are common symptoms of scleroderma, the causes of these symptoms and their long-term outcomes have not been fully studied. However, treatment options are available, such as aspirin or aspirin-like medications, which can help manage muscle pain and weakness associated with the condition.
Muscle Twitching: Why Your Arm is Acting Up
You may want to see also
Systemic sclerosis can cause digestive issues, such as swallowing difficulties and bloating
Systemic sclerosis is an autoimmune disease characterised by skin thickening and tightness. The condition can cause the hardening and thickening of connective tissue, impacting the functioning of muscles, blood vessels, joints, and internal organs.
The gastrointestinal (GI) tract is the most commonly damaged system in systemic sclerosis. The esophagus is the most frequently reported site of damage, with up to 96% of patients experiencing esophageal complications. These complications include motility abnormalities, lower esophageal sphincter (LES) abnormalities, gastroesophageal reflux disease (GERD), and Barrett's esophagus. Damage to the esophageal smooth muscle can cause dysphagia, or difficulty swallowing, which is a common complaint among patients. GERD, caused by pathological gastric acid reflux, further damages the LES and can lead to peptic esophagitis, erosive esophagitis, bleeding, and ulceration.
Other parts of the digestive system may also be affected, leading to bloating, diarrhoea, constipation, and abdominal distension. These symptoms are generally mild in the early stages of the disease and can be managed through dietary modifications, probiotics, and lifestyle changes. However, in severe cases, GI tract involvement can progress to malnutrition requiring parenteral nutrition.
It is crucial to spot these complications early and seek medical advice, as systemic sclerosis can sometimes lead to serious problems with internal organs.
Abilify Side Effects: Muscle Aches and Pains
You may want to see also
Frequently asked questions
Scleroderma, or systemic sclerosis, is an autoimmune condition in which the skin and connective tissue inside the body harden and thicken, becoming like scar tissue. This can affect muscles, blood vessels, joints, and internal organs.
Symptoms include pain, stiffness, swelling, warmth, or tenderness accompanying arthritis-like joint inflammation, as well as muscle pain and weakness. Other symptoms include Raynaud's phenomenon, where fingers or toes turn white and then blue in the cold due to narrowed blood vessels. In addition, scleroderma can cause heartburn, swallowing difficulties, bloating, diarrhoea, and constipation.
Scleroderma can cause muscle weakness and damage due to the accumulation of fibrous tissue in the muscles. This can lead to severe outcomes, including death from heart disease. However, the causes of muscle weakness in scleroderma and its long-term effects are not yet fully understood.
Treatment for muscle damage caused by scleroderma may include medications such as aspirin or non-steroidal, anti-inflammatory prescription drugs. Additionally, early detection is crucial, and regular check-ups with a doctor are recommended to monitor for potential complications.
